Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    November 2022
  1. ZHENG Y, Huang N, Kuang S, Zhang J, et al
    The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery.
    Cancer. 2022 Nov 26. doi: 10.1002/cncr.34552.
    PubMed     Abstract available


  2. NAKAGAWA M, Inoue M, Ogasawara S, Maruta S, et al
    Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice.
    Cancer. 2022 Nov 24. doi: 10.1002/cncr.34559.
    PubMed     Abstract available


  3. NIERENGARTEN MB
    Blood-based test to predict future risk of developing liver cancer: Researchers recently discovered a genetic signature that can help predict long-term hepatocellular carcinoma risk in patients who have nonalcoholic fatty liver disease, and may also h
    Cancer. 2022;128:3904.
    PubMed    


    October 2022
  4. CAO M, Li H, Sun D, He S, et al
    Assessment of the compliance, influencing factors, and yielding results of liver cancer screening in a high-risk population: A cross-sectional study.
    Cancer. 2022;128:3653-3662.
    PubMed     Abstract available


    September 2022
  5. LI Y, Liang X, Li H, Chen X, et al
    Atezolizumab plus bevacizumab versus nivolumab as first-line treatment for advanced or unresectable hepatocellular carcinoma: A cost-effectiveness analysis.
    Cancer. 2022 Sep 16. doi: 10.1002/cncr.34457.
    PubMed     Abstract available


  6. MATTINGLY TJ 2ND, Shetty K
    The economics of advanced and unresectable hepatocellular carcinoma.
    Cancer. 2022 Sep 15. doi: 10.1002/cncr.34456.
    PubMed    


    August 2022
  7. LEE YT, Singal AG, Lauzon M, Agopian VG, et al
    Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States.
    Cancer. 2022 Aug 23. doi: 10.1002/cncr.34436.
    PubMed     Abstract available


  8. JALAL PK
    Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat?
    Cancer. 2022 Aug 9. doi: 10.1002/cncr.34408.
    PubMed    


    July 2022
  9. PARIKH ND, Mehta N, Hoteit MA, Yang JD, et al
    Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
    Cancer. 2022 Jul 7. doi: 10.1002/cncr.34378.
    PubMed     Abstract available


    May 2022
  10. SHORT SS, Kastenberg ZJ, Wei G, Bondoc A, et al
    Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
    Cancer. 2022 May 13. doi: 10.1002/cncr.34256.
    PubMed     Abstract available


    April 2022
  11. DE B, Tran Cao HS, Vauthey JN, Manzar GS, et al
    Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States.
    Cancer. 2022 Apr 13. doi: 10.1002/cncr.34223.
    PubMed     Abstract available


    March 2022
  12. LEBECK LEE CM, Ziogas IA, Agarwal R, Alexopoulos SP, et al
    A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34170.
    PubMed     Abstract available


  13. ROBERTS HJ, Wo JY
    Stereotactic body radiation therapy for primary liver tumors: An effective liver-directed therapy in the toolbox.
    Cancer. 2022;128:956-965.
    PubMed     Abstract available


    January 2022
  14. NIERENGARTEN MB
    Aspirin decreases the risk of hepatocellular cancer in at-risk patients.
    Cancer. 2022;128:214-215.
    PubMed    


    November 2021
  15. KATZENSTEIN HM, Malogolowkin MH, Krailo MD, Piao J, et al
    Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
    Cancer. 2021 Nov 11. doi: 10.1002/cncr.34014.
    PubMed     Abstract available


    October 2021
  16. DUONG LM, Cai H, Shrubsole MJ, Bailey CE, et al
    Outcomes of robotic-assisted liver surgery versus laparoscopic liver surgery for treatment of stage I hepatocellular carcinoma.
    Cancer. 2021 Oct 21. doi: 10.1002/cncr.33979.
    PubMed     Abstract available


  17. CHENG K, Chen Y, Wang X, Xu M, et al
    Entecavir combined with interferon-alpha is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B.
    Cancer. 2021 Oct 8. doi: 10.1002/cncr.33949.
    PubMed     Abstract available


    August 2021
  18. HARDING JJ, Yang TS, Chen YY, Feng YH, et al
    Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study.
    Cancer. 2021 Aug 20. doi: 10.1002/cncr.33870.
    PubMed     Abstract available


    July 2021
  19. MERRIAM P, Nathenson MJ
    Liver transplantation for hepatic epithelioid hemangioendothelioma.
    Cancer. 2021 Jul 13. doi: 10.1002/cncr.33751.
    PubMed    


  20. DING X, Sun W, Li W, Shen Y, et al
    Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33677.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: